Spinocerebellar ataxia type-1 and spinobulbar muscular atrophy gene products interact with glyceraldehyde-3-phosphate dehydrogenase - Wikidata - awgldk - TriplyDB

Spinocerebellar ataxia type-1 and spinobulbar muscular atrophy gene products interact with glyceraldehyde-3-phosphate dehydrogenase

Spinocerebellar ataxia type-1 and spinobulbar muscular atrophy gene products interact with glyceraldehyde-3-phosphate dehydrogenase

http://www.wikidata.org/entity/Q28293728

about

Ataxin 1, a SCA1 neurodegenerative disorder protein, is functionally linked to the silencing mediator of retinoid and thyroid hormone receptors HIP1, a human homologue of S. cerevisiae Sla2p, interacts with membrane-associated huntingtin in the brain The structure of the AXH domain of spinocerebellar ataxin-1 Aberrant interactions of transcriptional repressor proteins with the Huntington's disease gene product, huntingtin S-nitrosylated GAPDH initiates apoptotic cell death by nuclear translocation following Siah1 binding The diverse functions of GAPDH: views from different subcellular compartments Identification of tissue transglutaminase-reactive lysine residues in glyceraldehyde-3-phosphate dehydrogenase The cerebellar leucine-rich acidic nuclear protein interacts with ataxin-1 Structural characterization of transglutaminase-catalyzed cross-linking between glyceraldehyde 3-phosphate dehydrogenase and polyglutamine repeats Reduction of glyceraldehyde-3-phosphate dehydrogenase activity in Alzheimer's disease and in Huntington's disease fibroblasts.Neurotoxicity of advanced glycation end-products for cultured cortical neurons.Pathogenesis of inclusion bodies in (CAG)n/Qn-expansion diseases with special reference to the role of tissue transglutaminase and to selective vulnerability.Polyglutamine pathogenesis.Analysis of exon 1 mutations in the androgen receptor gene.Oxidatively modified glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and Alzheimer's disease: many pathways to neurodegeneration ETS1 regulates the expression of ATXN2.Mutant huntingtin: nuclear translocation and cytotoxicity mediated by GAPDH Nonneural nuclear inclusions of androgen receptor protein in spinal and bulbar muscular atrophy.Ataxin-1 poly(Q)-induced proteotoxic stress and apoptosis are attenuated in neural cells by docosahexaenoic acid-derived neuroprotectin D1.Impaired GAPDH-induced mitophagy contributes to the pathology of Huntington's disease.Glyceraldehyde-3-phosphate dehydrogenase: nuclear translocation participates in neuronal and nonneuronal cell death.Transglutaminase-catalyzed inactivation of glyceraldehyde 3-phosphate dehydrogenase and alpha-ketoglutarate dehydrogenase complex by polyglutamine domains of pathological length Pharmacological protein targets in polyglutamine diseases: mutant polypeptides and their interactors.Glyceraldehyde-3-phosphate dehydrogenase enhances transcriptional activity of androgen receptor in prostate cancer cells.Intracellular processing and toxicity of the truncated androgen receptor: nuclear congophilia-associated cell death.Polyglutamine domain proteins with expanded repeats bind neurofilament, altering the neurofilament network.The dual role of a yeast metacaspase: What doesn't kill you makes you stronger.Molecular genetics and neurobiology of neurodegenerative and neurodevelopmental disorders.The CAG/polyglutamine tract diseases: gene products and molecular pathogenesis.Toward understanding the molecular pathology of Huntington's disease.Huntington's disease and dentatorubral-pallidoluysian atrophy: proteins, pathogenesis and pathology.Characterization of proteins associated with polyglutamine aggregates: a novel approach towards isolation of aggregates from protein conformation disorders.Induction of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) expression in rat brain after focal ischemia/reperfusion.Glyceraldehyde 3-phosphate dehydrogenase augments the intercellular transmission and toxicity of polyglutamine aggregates in a cell model of Huntington disease.Nuclear translocation of glyceraldehyde-3-phosphate dehydrogenase isoforms during neuronal apoptosis.Urinary diagnostic proteomic markers for dynapenia in cancer patients.Inhibition of α-ketoglutarate-and pyruvate dehydrogenase complexes in E. coli by a glutathione S-transferase containing a pathological length poly-Q domain: A possible role of energy deficit in neurological diseases associated with poly-Q expansions The AXH module: an independently folded domain common to ataxin-1 and HBP1

P2860

Q24316293-2A5999EE-C4CB-4D9C-B60F-D61793707DAD Q24318878-D53D058D-AEA0-43E7-9A19-93B27E971EBE Q27642446-5BE14FE1-2CBB-48BF-936F-8A1D2D489AF8 Q28141695-FC919A67-02D2-459D-9782-4A54C15F5ECE Q28256078-B3C0C569-326B-485F-B735-FEE50116EC58 Q28291106-BC21CB82-2705-4401-B16A-12E864337B5B Q28366199-4FA1EEC7-F99E-4321-B997-3479F4EC4A41 Q28589800-DBF2C6FD-6149-45F1-BB9E-21324B29118B Q31122113-CA264F15-925E-4169-8D6F-6010798139C0 Q32034809-CE4C5378-FAF4-4C20-8EFE-E067F28BB9EF Q33181556-85D00ED6-3203-4ECE-B833-4EDC1A358BA5 Q33536410-0B14B0D0-B6AF-4248-AC8F-F07D4DB73B4A Q33703910-3EF49A77-7289-4607-93BE-D6F85743E8DB Q33881302-726846A8-4F43-47F4-8F87-C336BBF3D910 Q34071097-F50BF4E8-B2FD-4603-A64A-03229C82F2FE Q34390181-9A3AA0D0-2F42-456A-B47D-43E347E43EF8 Q34480379-BC3A2178-F89B-4BDC-8669-0918A14D6AA5 Q35753336-CDF522F2-D060-491E-8588-22EE8FA0169E Q36078823-AD887661-6A5B-4DEB-BCCB-DB188FCCD52D Q36159463-BD5803BA-F4F0-4D7C-902A-714B1DCE8AA2 Q36605673-8027F3C5-E598-4AAF-9DEC-986DB259F5C4 Q36826440-3C775B43-7939-431C-AB4B-83423D6D6232 Q38107677-C19C8F86-BC84-4D3B-8B7A-82916BE9ABFA Q40123008-41EA5449-2EA5-47C5-97FB-8A59FA7BF7DF Q40859984-64BF8BB8-6B3A-4D06-BD98-DBCE12E5F0D9 Q40900388-B09E8CC2-19C8-42DA-A937-9429AB7F1D48 Q41349884-57E66C15-9F7A-4EFE-BE33-D49216BAD2A1 Q41452546-9848CCC7-B295-454B-A4B9-0B9D5C79D16C Q41527072-AF42646F-BB5C-4875-85C6-A224516B821B Q41527106-BD1D94EE-444F-4C55-A8F1-C218790B9F7A Q41527116-D8B5EDD4-A414-40DF-8986-EA6F99E12B58 Q43189336-A331E5A4-B1DF-4E89-91E4-0E514D5F83F0 Q43916282-5056DAD7-52F3-4404-8DBD-9849048C013B Q45291908-860D85A1-3608-4450-B64B-0F1CF5687E97 Q48275909-68C0A63C-E62D-4B5D-8436-8FB7F2329A74 Q55112476-3AB71B2E-680E-4743-A2C1-369456A5E7B4 Q57417893-DC6DD1A9-B33E-472B-8996-3536A1798205 Q57586996-5C8A2BBA-359F-4E6B-ABFD-BC8BAB84E531

P2860

Spinocerebellar ataxia type-1 and spinobulbar muscular atrophy gene products interact with glyceraldehyde-3-phosphate dehydrogenase

http://www.wikidata.org/entity/Q28293728

description

1996 nî lūn-bûn

@nan

1996 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

1996 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

1996年の論文

@ja

1996年論文

@yue

1996年論文

@zh-hant

1996年論文

@zh-hk

1996年論文

@zh-mo

1996年論文

@zh-tw

1996年论文

@wuu

name

Spinocerebellar ataxia type-1 ...... hyde-3-phosphate dehydrogenase

@ast

Spinocerebellar ataxia type-1 ...... hyde-3-phosphate dehydrogenase

@en

Spinocerebellar ataxia type-1 ...... hyde-3-phosphate dehydrogenase

@nl

type

label

Spinocerebellar ataxia type-1 ...... hyde-3-phosphate dehydrogenase

@ast

Spinocerebellar ataxia type-1 ...... hyde-3-phosphate dehydrogenase

@en

Spinocerebellar ataxia type-1 ...... hyde-3-phosphate dehydrogenase

@nl

prefLabel

Spinocerebellar ataxia type-1 ...... hyde-3-phosphate dehydrogenase

@ast

Spinocerebellar ataxia type-1 ...... hyde-3-phosphate dehydrogenase

@en

Spinocerebellar ataxia type-1 ...... hyde-3-phosphate dehydrogenase

@nl

P1433

Q28293728-E660FA50-588B-4E10-A249-DC402E157F22

P1476

Q28293728-857B1709-32FF-468E-B6EB-678471499995

P2093

Q28293728-1DFD52A8-17B7-44C4-9206-29643E0C7D16

Q28293728-29F3D383-DC23-4D36-9240-31F6B056A2B8

Q28293728-3C83CB37-F651-454D-BB4B-77C8195183E7

Q28293728-3CC5F34E-752A-4556-8163-1CABE2E5BEE1

Q28293728-43EF781F-1AD4-4379-9BF3-876ECC60DC46

P304

Q28293728-6077664A-260B-4111-8623-CB77BEFB4ED5

P31

Q28293728-09B4FC11-7D09-41ED-B0A2-40E9C9CA0A0A

P356

Q28293728-6B58DB77-6FA7-447E-BA2D-F7DD4748013B

P407

Q28293728-99256FE0-A2B8-439C-B36E-8BD172CE1E75

P433

Q28293728-0C7ECFB7-C283-435D-8231-4639FEB6289E

P478

Q28293728-F6DA8A25-381B-4EDC-BF81-841BA165C42F

P50

Q28293728-77D609FE-CCF1-4D73-A694-7984142BFC3F

Q28293728-C18AD065-FED3-4C59-A20B-42163293DE6F

P577

Q28293728-9C84330F-1746-4637-B235-2BAF364150A3

P5875

Q28293728-61793304-4347-4A14-8EB4-94D447BCCC23

P698

Q28293728-9A7F3423-4690-4DA7-A85D-C874608650C3

P921

Q28293728-61C7F50C-6D3E-4B1A-AD27-75CE7C097CA4

P356

P1433

Human Molecular Genetics

P1476

Spinocerebellar ataxia type-1 ...... hyde-3-phosphate dehydrogenase

@en

P2093

B Koshy

http://www.w3.org/2001/XMLSchema#string

D E Merry

http://www.w3.org/2001/XMLSchema#string

E N Burright

http://www.w3.org/2001/XMLSchema#string

H T Orr

http://www.w3.org/2001/XMLSchema#string

K H Fischbeck

http://www.w3.org/2001/XMLSchema#string

P304

1311-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/HMG/5.9.1311

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

P577

1996-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

14333318

http://www.w3.org/2001/XMLSchema#string

P698

8872471

http://www.w3.org/2001/XMLSchema#string

P921